Atlas Trials

UPLC-MS/MS Monitoring of Emicizumab Therapy

Clinical trial NCT04472169 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04472169
Sponsor
University Hospital, Lille
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Hemophilia A
Start date
2022-04-13
Primary completion
2026-11-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.